Birth Control

LNG IUD as EC, IUD pain management, thrombosis risks with hormonal contraception, telehealth & medication abortion, adolescent contraception guidance

A 19 year-old patient (he/him) comes to your emergency department in the early morning. He is seeking HIV post-exposure prophylaxis (PEP) following unprotected sex with a male partner the night before. During intake, he discloses that he is transgender and was assigned female at birth (AFAB). He is amenorrheic as a result of testosterone use for gender-affirming hormone therapy. At your facility, cisgender women seeking PEP are also offered EC.

Cancer and contraception, menstrual cups and IUD displacement, vaginal microbiome and contraceptives, OTC birth control knowledge gaps, early medication abortion follow-up

A 25 year-old patient (she/her) is interested in starting birth control four weeks after having her first child. She is breastfeeding but needs to supplement formula one to two bottles a day because of “not having enough milk.” Prior to pregnancy she was happy with a hormonal implant but is unsure if this method is safe while producing milk.

Infection prevention after abortion, estetrol in oral contraceptives, postpartum implant placement and breastfeeding, SAHM position statements

Partner treatment for BV, pain and bleeding experiences during first-trimester abortion, interest in Rh testing and treatment for telehealth medication abortion.

New flexible IUD expands options for highly effective, non-hormonal birth control

Double dosing UPA for EC not needed for BMI > 30, postpartum implant placement and milk supply, mifepristone to increase efficacy of medication management of EPL.